The Global Rheumatology Therapeutic Market is
anticipated to rise at a significant CAGR in the forthcoming period. Rheumatic
diseases are inflammatory and are better known as rheumatoid arthritis or
systemic lupus erythematosus (SLE). Being severe and chronic by nature, these
diseases affect every age group and may cause deterioration of quality of life
and pose a major health care burden across the globe. Ongoing developments for
novel therapies which are efficient and cost-effective in terms of diagnosis.
For instance, steroids and non-steroidal anti-inflammatory drugs are introduced
into therapy of inflammatory rheumatic diseases.
Browse Full Research Report @ https://www.millioninsights.com/industry-reports/rheumatology-therapeutic-market
At present, therapeutic drug monitoring and pharmacogenomics
are two techniques to diagnose rheumatic diseases. From the commercial
standpoint, pharmacogenetic tests have made up to rheumatic diseases. Driving
factors responsible for the growth of rheumatology therapeutic industry
includes rise in geriatric population and rise in disposable income coupled
with adoption of biosimilars.
Segmentation based on drug class for rheumatology
therapeutic market includes disease modifying anti-rheumatic drugs,
nonsteroidal anti-inflammatory drugs, corticosteroids, uric acid. Segmentation
based on disease indication for the market includes rheumatoid arthritis,
osteoarthritis, psoriatic arthritis, gout and ankylosing spondylitis.
Segmentation based on distribution channel for rheumatology therapeutic
industry includes hospital, online pharmacy and retail pharmacy.
Request Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/rheumatology-therapeutic-market/request-sample
Geographical segmentation for rheumatology therapeutic
market spans North America, South America, Europe, Asia-Pacific, Middle-East
and Africa. North America market is expected to dominate the market growth
owing to rise in geriatric population suffering from rheumatology disorders. In
addition, inclination towards biosimilar and biologics products to diagnose
moderate and severe rheumatoid arthritis coupled with specialty centers and
healthcare facilities is expected to boost the growth of rheumatology
therapeutic industry in the forthcoming period.
Europe and APAC market is expected to gain a significant
share in the rheumatology therapeutic industry due to rise in geriatric
population and establishment of healthcare facilities. Other factors such as
rise in per capita healthcare expenditure and adoption of biosimilars to
diagnose rheumatology disorders. The key players in rheumatology therapeutic
market include Abbott, Pfizer, Amgen, Janssen Biotech, Merck and Co Inc, Squibb
Company, Bristol-Myers, Novartis AG, Biotech Inc, Genentech Inc and Takeda
Pharmaceutical.
See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/therapeutic-area
No comments:
Post a Comment